Exabis Library
Welcome to the e-CCO Library!
DOP62: Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP62: Medication use is increased in the decade prior to IBD diagnosis: A nationwide cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP62: Medication use is increased in the decade prior to IBD diagnosis: A nationwide cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP62: Morbidity after primary ileocecal resection for Crohn’s Disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP62: Morbidity after primary ileocecal resection for Crohn’s Disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP63 Efficacy and safety of iron carboxymaltose on chronic fatigue in patients with inflammatory bowel disease: a randomised controlled trial
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP63: Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
Wednesday, 27 February 2019, 4:37 PM by ECCO Administrator
DOP63: Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP63: Efficacy and safety of iron carboxymaltose on chronic fatigue in patients with Inflammatory Bowel Disease: A randomized controlled trial
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP63: Efficacy and safety of iron carboxymaltose on chronic fatigue in patients with Inflammatory Bowel Disease: A randomized controlled trial
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP63: Mortality in Pediatric-onset Immune-Mediated Inflammatory Disease – A Nationwide Study.
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP63: Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP63: The Toronto IBD global endoscopic reporting (TIGER) score is well correlated with fecal calprotectin and IBD Disk in Ulcerative Colitis patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP63: Time Trends of Environmental and Socio-economical Factors in Patients with Inflammatory Bowel Disease over 40-year of Different Therapeutic Eras; results from a Population-based Cohort from Western Hungarian between 1977-2020, The Hygiene hypothesis revisited.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP63: Time Trends of Environmental and Socio-economical Factors in Patients with Inflammatory Bowel Disease over 40-year of Different Therapeutic Eras; results from a Population-based Cohort from Western Hungarian between 1977-2020, The Hygiene hypothesis revisited.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP64 Discovery of highly selective small-molecule oral inhibitors of integrin α4β7 for the treatment of inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP64: Discovery of highly selective small molecule oral inhibitors of integrin α4β7 for the treatment of Inflammatory Bowel Diseases
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP64: Discovery of highly selective small molecule oral inhibitors of integrin α4β7 for the treatment of Inflammatory Bowel Diseases
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP64: Endoscopically injected allogeneic mesenchymal stromal cells alter the mucosal immune cell compartment in patients with ulcerative proctitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP64: Minimal additional benefits in adding faecal haemoglobin to faecal calprotectin in predicting endoscopic disease activity in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM